Adults 13 to 80, any sex, with Anterior Cruciate Ligament Injury. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Pain While at RestPrimary· 24 hours post-block administration
Average numerical rating scale (NRS) at rest. A lower score is a better outcome. scale ranges from 0 to 10.
Group
Value
95% CI
Adductor Canal Block (ACB)
3.84
± 1.86
Adductor Canal Block & IPACK (ACB/IPACK)
3.95
± 2.58
Discharge CriteriaSecondary· From 3 hours post-block administration on Post-operative day (POD) 0 until met discharge criteria, assessed up to 1 day
Time to meet discharge criteria utilizing the modified post anesthetic discharge scoring system. The frame represents when the measurements began, i.e. 3 hours after the administration of the anesthetic block. This represents time zero, at which recording would then begin.
Group
Value
95% CI
Adductor Canal Block (ACB)
180.67
± 143.84
Adductor Canal Block & IPACK (ACB/IPACK)
189.92
± 254.55
Pain With AmbulationSecondary· 3 hours post-block administration on Post-operative day (POD) 0
NRS Pain score with ambulation \& stairs. A lower score is a better outcome. Score range is from 0 to 10.
NRS with Ambulation
Group
Value
95% CI
Adductor Canal Block (ACB)
1.59
± 1.43
Adductor Canal Block & IPACK (ACB/IPACK)
1.26
± 1.23
NRS with Stairs
Group
Value
95% CI
Adductor Canal Block (ACB)
2.05
± 1.92
Adductor Canal Block & IPACK (ACB/IPACK)
2.1
± 1.81
Sponsor's own description
A comparison of two anesthetic techniques-- the Adductor Canal Block (ACB) and the Adductor Canal Block with Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (ACB/IPACK)-- in patients undergoing bone-tendon-bone (BTB) anterior cruciate ligament (ACL) reconstruction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia
· NA
· not yet recruiting
NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip
· Phase 3
· recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery
· Phase 2
· recruiting
NCT07430085 — Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA
· Phase 4
· not yet recruiting
NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study
· Phase 4
· not yet recruiting
Other recruiting trials for Anterior Cruciate Ligament Injury
Currently open trials in the same condition.
NCT06357091 — ACL Reconstruction With Shark Screw® or Biocomposite-interference Screws
· NA
· recruiting
NCT05527171 — Virtual Reality Mindfulness Meditation After ACL Reconstruction
· NA
· recruiting
NCT03935750 — STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon
· NA
· active not recruiting
NCT03348995 — The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration
· NA
· active not recruiting
Other Hospital for Special Surgery, New York trials
Trials by the same sponsor.
NCT07226700 — Suzetrigine in Total Hip Arthroplasty
· Phase 3
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital for Special Surgery, New York
Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03292926.